Strong performance in Q3 and FY guidance (only) confirmed.

Successsful listing of TKMS is encouraging.

Best ever quarterly sales.

Miss in Q1: No recovery in China and US

Encouraging QA3 with growth resuming in China.

Profit warning was largely expected.